Work

Phase 3, randomized, placebo-controlled trials evaluating glasdegib in combination with intensive or nonintensive chemotherapy in patients with untreated acute myeloid leukemia.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.tps7073

Authors: Jorge E. Cortes, Hervé Dombret, Akil Abid Merchant, Tetsuzo Tauchi, Christine DiRienzo, Mirjana Zeremski, Barbara Sleight, Xiaoxi Zhang, Mohammed Naveed Shaik, Timothy Bell, Geoffrey Chan, Mikkael A. Sekeres

Institutions: The University of Texas MD Anderson Cancer Center, Hôpital Saint-Louis, University of Southern California, Tokyo Medical University, Pfizer (United States), Cleveland Clinic

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2891157069

Cites:

Cited by: 5

Related to: 10